Precigen Stock Debt To Equity
| I5X Stock | EUR 0.85 0.07 8.97% |
Precigen fundamentals help investors to digest information that contributes to Precigen's financial success or failures. It also enables traders to predict the movement of Precigen Stock. The fundamental analysis module provides a way to measure Precigen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Precigen stock.
Precigen |
Precigen Company Debt To Equity Analysis
Precigen's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.
Current Precigen Debt To Equity | 1.05 % |
Most of Precigen's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Precigen is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.
| Competition |
According to the company disclosure, Precigen has a Debt To Equity of 1.053%. This is 98.03% lower than that of the Healthcare sector and 94.56% lower than that of the Biotechnology industry. The debt to equity for all Germany stocks is 97.84% higher than that of the company.
Precigen Debt To Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Precigen's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Precigen could also be used in its relative valuation, which is a method of valuing Precigen by comparing valuation metrics of similar companies.Precigen is currently under evaluation in debt to equity category among its peers.
Precigen Fundamentals
| Return On Equity | -0.51 | |||
| Return On Asset | -0.12 | |||
| Profit Margin | 0.21 % | |||
| Operating Margin | (0.52) % | |||
| Current Valuation | 326.26 M | |||
| Shares Outstanding | 251.01 M | |||
| Shares Owned By Insiders | 10.09 % | |||
| Shares Owned By Institutions | 55.62 % | |||
| Price To Book | 2.33 X | |||
| Price To Sales | 2.70 X | |||
| Revenue | 103.87 M | |||
| Gross Profit | (4.65 M) | |||
| EBITDA | (64.27 M) | |||
| Net Income | (92.17 M) | |||
| Cash And Equivalents | 105.69 M | |||
| Cash Per Share | 0.51 X | |||
| Total Debt | 182.75 M | |||
| Debt To Equity | 1.05 % | |||
| Current Ratio | 5.71 X | |||
| Book Value Per Share | 0.69 X | |||
| Cash Flow From Operations | (55.77 M) | |||
| Earnings Per Share | (0.35) X | |||
| Target Price | 12.5 | |||
| Number Of Employees | 456 | |||
| Beta | 1.87 | |||
| Market Capitalization | 267.45 M | |||
| Total Asset | 359.86 M | |||
| Z Score | 0.6 | |||
| Net Asset | 359.86 M |
About Precigen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Precigen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Precigen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Precigen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Precigen Stock
When determining whether Precigen offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Precigen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Precigen Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Precigen Stock:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Precigen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Precigen Stock please use our How to Invest in Precigen guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.